Independent Director · Definium Therapeutics, Inc. (DFTX)

Andreas Krebs — Definium Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Andreas Krebs at Definium Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Andreas Krebs’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Andreas Krebs and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Definium Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Definium Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$85,000$0$399,827$0$484,827
FY2024$86,359$0$98,671—$185,030
FY2023$87,500$49,352$49,352—$186,204
FY2021$25,625$43,125$34,519—$103,269

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Definium Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-182034, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Definium Therapeutics, Inc. filed document, accession 0001193125-26-182034. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

Get the Definium Therapeutics Board Governance Report

$484,827 Andreas Krebs, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Definium Therapeutics pays directors a $40,000 cash retainer and $450,000 in Options/RSUs/PSUs.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance

The rest of the Definium Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Carol A. ValloneChair of the Board$496,827
David GryskaIndependent Director$458,827
Dr. Roger CrystalIndependent Director$456,827
Dr. Suzanne BruhnIndependent Director$457,827
Robert BarrowDirector—
Roger AdsettIndependent Director—

The full Definium Therapeutics compensation record

free company brief

This page is one director within Definium Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order DFTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report